RTP-based Qualyst, Inc. (www.qualyst.com), has received a two-year, $160,000 grant from the North Carolina Biotechnology Center and The Kenan Institute to conduct collaborative research in partnership with UNC-Chapel Hill. Officials said the grant will fund research in the laboratories of Dr. Dhiren R. Thakker, School of Pharmacy, UNC-Chapel Hill, toward continued development and refinement of technologies for high throughput screening of drug candidates to assess metabolic stability.
In addition to the grant announcement, Qualyst has also appointed Dr. Ian Mehr as its Senior Director of Business Development. Dr. Mehr has more than 10 years of experience in the life sciences industry, spanning both research and business development. Qualyst is developing technologies for the drug discovery and development marketplace. The company's products allow researchers to predict with greater accuracy the disposition of a particular drug within the human body.